Vivo Bio Tech Limited (BOM:511509)

Market Cap	699.10M
Revenue (ttm)	466.73M
Net Income (ttm)	72.83M
Shares Out	18.38M
EPS (ttm)	4.76
PE Ratio	7.99
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,566
Average Volume	44,825
Open	38.79
Previous Close	38.06
Day's Range	37.50 - 38.79
52-Week Range	31.20 - 56.90
Beta	0.39
RSI	48.94
Earnings Date	May 20, 2025

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory...

• Industry: Commercial Physical and Biological Research
• Founded: 1987
• Employees: 161
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 511509

Financial Performance

In 2024, Vivo Bio Tech's revenue was 466.73 million, an increase of 2.69% compared to the previous year's 454.51 million. Earnings were 72.83 million, an increase of 188.27%.